(OCSL) Oaktree Specialty Lending - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US67401P1084
OCSL: Loans, Debt, Equity, Investments
Oaktree Specialty Lending Corporation (NASDAQ: OCSL) is a business development company that focuses on providing debt and equity financing solutions to middle-market companies. The firm is part of Oaktree Capital Management, a well-regarded global investment manager with a strong track record in credit markets. OCSL specializes in first and second lien debt, mezzanine financing, and preferred equity investments, targeting small and mid-sized businesses with enterprise values between $20 million and $150 million.
The company’s investment strategy is sector-agnostic, with a focus on industries such as business services, healthcare, manufacturing, retail, and technology. It also invests in niche sectors like education, restaurants, and pharmaceuticals. OCSL typically invests between $5 million and $75 million per transaction, with the flexibility to underwrite larger deals up to $100 million. Its portfolio companies generally have EBITDA ranging from $3 million to $50 million, indicating a focus on stable cash flow generation.
As a lead investor, Oaktree Specialty Lending seeks to structure transactions that provide both senior and junior debt, often pairing these with equity co-investments. This approach allows the firm to align its interests with those of its portfolio companies while providing tailored capital solutions. The company primarily operates in North America, leveraging Oaktree’s extensive network and expertise in credit markets.
From a financial standpoint, OCSL has a market capitalization of approximately $1.28 billion, with a price-to-book ratio of 0.88, indicating that the stock is trading below its book value. The forward P/E ratio of 7.97 suggests that investors expect earnings growth in the coming years. The firm’s investment portfolio is sizable, with a hold size of up to $75 million per investment, reflecting its capacity to support mid-sized businesses through various stages of growth.
For investors and fund managers, OCSL offers exposure to a diversified portfolio of middle-market companies across multiple industries. Its focus on debt financing with equity participation provides a balanced risk-return profile, making it an attractive option for those seeking yield in the private credit space. The firm’s affiliation with Oaktree Capital Management adds credibility and operational expertise, which are critical factors for investors evaluating BDCs.
Additional Sources for OCSL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OCSL Stock Overview
Market Cap in USD | 1,323m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2008-06-12 |
OCSL Stock Ratings
Growth 5y | 34.9% |
Fundamental | 2.71% |
Dividend | 96.1% |
Rel. Strength Industry | -30 |
Analysts | 3/5 |
Fair Price Momentum | 16.62 USD |
Fair Price DCF | 45.22 USD |
OCSL Dividends
Dividend Yield 12m | 13.56% |
Yield on Cost 5y | 23.66% |
Annual Growth 5y | 12.61% |
Payout Consistency | 91.1% |
OCSL Growth Ratios
Growth Correlation 3m | 39% |
Growth Correlation 12m | -76.3% |
Growth Correlation 5y | 82.6% |
CAGR 5y | 11.47% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | -0.82 |
Alpha | -22.21 |
Beta | 0.53 |
Volatility | 14.91% |
Current Volume | 509.8k |
Average Volume 20d | 670.7k |
As of February 22, 2025, the stock is trading at USD 16.03 with a total of 509,844 shares traded.
Over the past week, the price has changed by +1.58%, over one month by +1.97%, over three months by +6.68% and over the past year by -8.93%.
Neither. Based on ValueRay Fundamental Analyses, Oaktree Specialty Lending is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 2.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OCSL as of February 2025 is 16.62. This means that OCSL is currently overvalued and has a potential downside of 3.68%.
Oaktree Specialty Lending has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold OCSL.
- Strong Buy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, OCSL Oaktree Specialty Lending will be worth about 19.2 in February 2026. The stock is currently trading at 16.03. This means that the stock has a potential upside of +19.9%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 15.9 | -0.7% |
Analysts Target Price | 16.9 | 5.6% |
ValueRay Target Price | 19.2 | 19.9% |